- Merck & Co. (New York, NY)
- …and publication in the relevant therapeutic area space is highly desirable (ie, experience in late stage clinical research as an investigator or key study ... Medical Needs Execute - Prioritize Resources Behind Our Key Growth Drivers ( Oncology , Vaccines, Select Specialty Areas, Animal Health) While Optimizing Our Base… more
- Pfizer (New York, NY)
- …the development strategy for programs within our Late - Stage Oncology portfolio. **KEY RESPONSIBILITIES** + Clinical development expert for assigned ... studies maintaining current scientific and clinical knowledge in the specific therapeutic and disease area(s)...experience in the phase 2 - 3/pivotal space in Oncology , ideally on the side of the sponsor and… more
- Sumitomo Pharma (Albany, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- BMO Financial Group (New York, NY)
- …Ability to analyze clinical trial design and data across early and late - stage oncology trials (including dose escalation, dose-expansion, PFS/OS and ... to assess viability, competitive positioning, and likelihood of success of pre- clinical and clinical - stage oncology assets + Strong financial modeling… more
- Sumitomo Pharma (Albany, NY)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and… more
- Sumitomo Pharma (Albany, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Sumitomo Pharma (Albany, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Sumitomo Pharma (Albany, NY)
- …Experience in conducting global clinical trials in both early- and late - stage clinical development, especially protocol development and trial initiation ... study concept to clinical study protocol for both early- and late - stage programs + Leads or joins multi-disciplinary, multi-regional, matrix team through… more
- Sumitomo Pharma (Albany, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... motivated, and experienced individual for the position of **Associate** **Medical Director, Clinical Development - Oncology ** . The associate medical director is… more
- Sumitomo Pharma (Albany, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... a primary focus on advancing translational research to support oncology programs in clinical trial stages. This...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
